Bio
Mr. Kroloff is a Partner of NGN Capital. Noah J. Kroloff has 20 years of experience in healthcare, including senior operating roles. Prior to joining NGN Capital, Mr. Kroloff was an executive officer of i-STAT Corporation (Nasdaq: STAT), a medical device company where he served as Vice President for International Sales & Marketing and Corporate Development. He was actively involved in the sale of i-STAT to Abbott Laboratories for approximately $450 million. He also led the creation of a global alliance with Abbott and a $61 million alliance with Hewlett-Packard Medical Products Group, created i-STAT’s international distribution network and led licensing and deal-making activities. Prior to i-STAT, Mr. Kroloff was an Engagement Manager at McKinsey & Co. where he advised leading pharmaceutical and diagnostic companies on R&D management, portfolio strategy, and alliance formation. He has also performed significant work for Merck and Rosetta Genomics. Prior to his work in healthcare, he was a senior analyst at Fannie Mae and an associate at Industrial Economics, Inc. Mr. Kroloff received his BA in general science from Brandeis University and his MBA from the MIT Sloan School where he co-founded and serves as a judge of the MIT $100K Entrepreneurship Competition. Mr. Kroloff is a member of the Board of Directors of BeneChill, Inc., Valtech Cardio Ltd. and Coagulation Sciences LLC, serves as a board observer of Cerapedics, Inc., is actively involved with OptiScan Biomedical Corp. and recently served as a member of McKinsey’s alumni advisory council for 6 years.
Career
|
NGN Capital LLCEmail: [email protected] |
||
|
McKinsey & CoGlobal management consulting firm. |